Anti-EGFRvIII Chimeric Antigen Receptor-Modified T Cells for Adoptive Cell Therapy of Glioblastoma

Glioblastoma (GBM) is one of the most devastating brain tumors with poor prognosis and high mortality. Although radical surgical treatment with subsequent radiation and chemotherapy can improve the survival, the efficacy of such regimens is insufficient because the GBM cells can spread and destroy n...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Pei-pei, Li, Ming, Li, Tian-fang, Han, Shuang-yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470055/
https://www.ncbi.nlm.nih.gov/pubmed/28302023
http://dx.doi.org/10.2174/1381612823666170316125402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470055/
https://www.ncbi.nlm.nih.gov/pubmed/28302023
http://dx.doi.org/10.2174/1381612823666170316125402

Ejemplares similares